Conditional Tat protein brain expression in the GT-tg bigenic mouse induces cerebral fractional anisotropy abnormalities

Current HIV Research

Volumn 13, Issue 1, 2015, Pages 3-9

  Carey, Amanda N ^a   Liu, Xiaoxu ^b   Mintzopoulos, Dionyssios ^b   Paris, Jason J ^c   McLaughlin, Jay P ^a,c   Kaufman, Marc J ^b  

^a NORTHEASTERN UNIVERSITY   (United States)

^b MCLEAN HOSPITAL   (United States)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Diffusion tensor imaging; Fractional anisotropy; GT tg mouse; HIV; Tat

Indexed keywords

DOXYCYCLINE; TRANSACTIVATOR PROTEIN;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE COURSE; DISEASE SEVERITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIOLOGICAL FRACTIONAL ANISOTROPY; RADIOLOGICAL PARAMETERS; ANIMAL; ANIMAL MODEL; ANISOTROPY; BRAIN CHEMISTRY; DRUG EFFECTS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; TRANSGENIC ANIMAL; WHITE MATTER;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANISOTROPY; BRAIN CHEMISTRY; DOXYCYCLINE; GENE PRODUCTS, TAT; MAGNETIC RESONANCE IMAGING; MICE; MODELS, ANIMAL; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; WHITE MATTER;

EID: 84930972773     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X13666150126125244     Document Type: Article

References (76)

1. [1] Grant I, Atkinson JH, Hesselink JR, et al. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987; 107: 828-36. Erratum in: Ann Intern Med 1988; 108: 496.PMID: 3688675.
2. [2] Chrysikopoulos HS, Press GA, Grafe MR, Hesselink JR, Wiley CA. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990; 175: 185-91.PMID: 2315479
3. [3] Broderick DF, Wippold FJ, Clifford DB, Kido D, Wilson BS. White matter lesions and cerebral atrophy on MR images in patients with and without AIDS dementia complex. AJR Am J Roentgenol. 1993; 161: 177-81.PMID: 8517298
4. [4] Jernigan TL, Archibald S, Hesselink JR, et al. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol. 1993; 50: 250-5.PMID: 8442702
5. [5] Filippi CG, Ulug AM, Ryan E, Ferrando SJ, van Gorp W. Diffusion tensor imaging of patients with HIV and normalappearing white matter on MR images of the brain. AJNR Am J Neuroradiol. 2001; 22: 277-83.PMID: 11156769
6. [6] Archibald SL, Masliah E, Fennema-Notestine C, et al. Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol. 2004; 61: 369-76.PMID: 15023814
7. [7] Pfefferbaum A, Rosenbloom MJ, Rohlfing T, et al. Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage 2006; 33: 239-51.PMID: 16877010
8. [8] Thompson PM, Dutton RA, Hayashi KM, et al. 3D mapping of ventricular and corpus callosum abnormalities in HIV/AIDS. Neuroimage 2006; 31: 12-23.PMID: 16427319
9. [9] Chiang MC, Dutton RA, Hayashi KM, et al. 3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage 2007; 34: 44-60.PMID: 17035049
10. [10] Cardenas VA, Meyerhoff DJ, Studholme C, et al. Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol. 2009; 15: 324-33.PMID: 19499454
11. [11] Jernigan TL, Archibald SL, Fennema-Notestine C, et al. CHARTER Group. Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol. 2011; 17: 248-57.PMID: 21544705
12. [12] Hua X, Boyle CP, Harezlak J, et al. HIV Neuroimaging Consortium. Disrupted cerebral metabolite levels and lower nadir CD4 + counts are linked to brain volume deficits in 210 HIVinfected patients on stable treatment. Neuroimage Clin. 2013; 3: 132-42.PMID: 24179857
13. [13] Thurnher MM, Castillo M, Stadler A, Rieger A, Schmid B, Sundgren PC. Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients. AJNR Am J Neuroradiol. 2005; 26: 2275-81.PMID: 16219833
14. [14] Wu Y, Storey P, Cohen BA, Epstein LG, Edelman RR, Ragin AB. Diffusion alterations in corpus callosum of patients with HIV. AJNR Am J Neuroradiol. 2006; 27: 656-60.PMID: 16552012
15. [15] Chang L, Wong V, Nakama H, et al. Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol. 2008; 3: 265-74.PMID: 18709469
16. [16] Chen Y, An H, Zhu H, et al. White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage 2009; 47: 1154-62.PMID: 19376246
17. [17] Muller-Oehring EM, Schulte T, Rosenbloom MJ, Pfefferbaum A, Sullivan EV. Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study. Neuropsychologia 2010; 48: 1133-43.PMID: 20018201
18. [18] Leite SC, Correa DG, Doring TM, et al. Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients. J Magn Reson Imaging 2013; 38: 1488-93.PMID: 23559497
19. [19] Zhu T, Zhong J, Hu R, et al. Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study. J Neurovirol. 2013; 19: 10-23.PMID: 23179680
20. [20] Ragin AB, Storey P, Cohen BA, Epstein LG, Edelman RR. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol. 2004; 25: 195-200.PMID: 14970017
21. [21] Pomara N, Crandall DT, Choi SJ, Johnson G, Lim KO. White matter abnormalities in HIV-1 infection: a diffusion tensor imaging study. Psychiatry Res. 2001; 106: 15-24.PMID: 11231096
22. [22] Pfefferbaum A, Rosenbloom MJ, Rohlfing T, Kemper CA, Deresinski S, Sullivan EV. Frontostriatal fiber bundle compromise in HIV infection without dementia. AIDS 2009; 23: 1977-85.PMID: 19730350
23. [23] Gongvatana A, Schweinsburg BC, Taylor MJ, et al. Charter Group. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009; 15: 187-95.PMID: 19306228
24. [24] Ragin AB, Wu Y, Storey P, Cohen BA, Edelman RR, Epstein LG. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus. J Neurovirol. 2005; 11: 292-8.PMID: 16036809
25. [25] Bucy DS, Brown MS, Bielefeldt-Ohmann H, et al. Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol. 2011; 17: 341-52.PMID: 21786078
26. Lentz MR, Peterson KL, Ibrahim WG, et al. Diffusion Tensor and Volumetric Magnetic Resonance Measures as Biomarkers of Brain Damage in a Small Animal Model of HIV. PLoS One. 2014; 9(8): e105752.PMID: 25144656
27. [27] Li C, Zhang X, Komery A, Li Y, Novembre FJ, Herndon JG. Longitudinal diffusion tensor imaging and perfusion MRI investigation in a macaque model of neuro-AIDS: a preliminary study. Neuroimage 2011; 58: 286-92.PMID: 21658455
28. [28] Parada CA, Roeder RG. A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. EMBO J. 1999; 18: 3688-701.PMID: 10393184
29. [29] Rappaport J, Joseph J, Croul S, et al. Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol. 1999; 65: 458-65.PMID: 10204574
30. [30] Agbottah E, Zhang N, Dadgar S, et al. Inhibition of HIV-1 virus replication using small soluble Tat peptides. Virology 2006; 345: 373-389.PMID: 16289656
31. [31] King JE, Eugenin EA, Buckner CM, Berman JW. HIV tat and neurotoxicity. Microbes Infect. 2006; 8: 1347-57.PMID: 16697675
32. [32] Hauser KF, El-Hage N, Buch S, et al. Impact of opiate-HIV-1 interactions on neurotoxic signaling. J Neuroimmune Pharmacol. 2006; 1: 98-105.PMID: 18040795
33. [33] Hauser KF, Knapp PE. Interactions of HIV and Drugs of Abuse: The Importance of Glia, Neural Progenitors, and Host Genetic Factors. Int Rev Neurobiol. 2014; 118: 231-313.PMID: 25175867
34. [34] Paris JJ, Fenwick J, McLaughlin JP. Progesterone protects normative anxiety-like responding among ovariectomized female mice that conditionally express the HIV-1 regulatory protein, Tat, in the CNS. Horm Behav. 2014; 65: 445-53.PMID: 24726788
35. Meulendyke KA, Queen SE, Engle EL, Shirk EN, Liu J, Steiner JP, Nath A, Tarwater PM, Graham DR, Mankowski JL, Zink MC. Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease. J Neurovirol. 2014; 20: 591-602. PubMed PMID: 25227932
36. Steiner JP, Bachani M, Wolfson-Stofko B, Lee MH, Wang T, Li G, Li W, Strayer D, Haughey NJ, Nath A. Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection. Neurotherapeutics in press. PMID: 25404050
37. [37] Mousseau G, Clementz MA, Bakeman WN, et al. An analog of the natural steroidal alkaloid Cortistatin A potently suppresses Tatdependent HIV transcription. Cell Host & Microbe 2012; 12: 97-108.PMID: 22817991
38. [38] Zeiger M, Stark S, Kalden E, Ackermann B, Ferner J, Scheffer U, Shoja-Bazargani F, Erdel V, Schwalbe H, Gobel MW. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR. Bioorg Med Chem Lett. 2014; 24: 5576-80.PMID: 25466178
39. [39] Purohit V, Rapaka RS, Rutter J. Cannabinoid receptor-2 and HIVassociated neurocognitive disorders. J Neuroimmune Pharmacol. 2014; 9: 447-53.PMID: 25015040
40. [40] Carey AN, Sypek EI, Singh HD, Kaufman MJ, McLaughlin JP. Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res. 2012; 229: 48-56.PMID: 22197678
41. Hahn YK, Podhaizer EM, Farris SP, Miles MF, Hauser KF, Knapp PE. Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Struct Funct. In press. PMID: 24352707
42. [42] Fitting S, Ignatowska-Jankowska BM, Bull C, et al. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice. Biol Psychiatry 2013; 73: 443-453.PMID: 23218253
43. [43] Paris JJ, Singh HD, Ganno ML, Jackson P, McLaughlin JP. Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat. Psychopharmacology (Berl). 2014; 231: 2349-60.PMID: 24352568
44. [44] Kim BO, Liu Y, Ruan Y, Xu ZC, Schantz L, He JJ. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline. Am J Pathol. 2003; 162: 1693-707.PMID: 12707054
45. [45] Carey AN, Liu X, Mintzopoulos D, et al. Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions. Prog Neuropsychopharmacol Biol Psychiatry 2013; 43: 49-54.PMID: 23269344
46. [46] Cyr M, Caron MG, Johnson GA, Laakso A. Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction. Neuroimage 2005; 26: 83-90.PMID: 15862208
47. [47] Boretius S, Michaelis T, Tammer R, Ashery-Padan R, Frahm J, Stoykova A. In vivo MRI of altered brain anatomy and fiber connectivity in adult pax6 deficient mice. Cereb Cortex 2009; 19: 2838-47.PMID: 19329571
48. [48] Lehmann HC, Zhang J, Mori S, Sheikh KA. Diffusion tensor imaging to assess axonal regeneration in peripheral nerves. Exp Neurol. 2010; 223: 238-44.PMID: 19879260
49. [49] Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol. 2000; 12: 191-200.PMID: 11568431
50. [50] Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 2007; 35: 467-77.PMID: 17258908
51. [51] Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed. 2002; 15: 435-55.PMID: 12489094
52. [52] Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV. Diffusion tensor imaging of deep gray matter brain structures: effects of age and iron concentration. Neurobiol Aging 2010; 31: 482-93.PMID: 18513834
53. [53] Budde MD, Janes L, Gold E, Turtzo LC, Frank JA. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain 2011; 134: 2248-60.PMID: 21764818
54. [54] Bouix S, Pasternak O, Rathi Y, Pelavin PE, Zafonte R, Shenton ME. Increased gray matter diffusion anisotropy in patients with persistent post-concussive symptoms following mild traumatic brain injury. PLoS One 2013; 8(6):e66205.PMID: 23776631
55. [55] Aksenov MY, Hasselrot U, Bansal AK, et al. Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett. 2001; 305: 5-8.PMID: 11356294
56. [56] Aksenov MY, Hasselrot U, Wu G, et al. Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res. 2003; 987: 1-9.PMID: 14499939
57. [57] Wang GJ, Chang L, Volkow ND, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004; 127: 2452-8.PMID: 15319273
58. [58] Sporer B, Linke R, Seelos K, Paul R, Klopstock T, Pfister HW. HIV-induced chorea: evidence for basal ganglia dysregulation by SPECT. J Neurol. 2005; 252: 356-8.PMID: 15726276
59. [59] Gelman BB, Spencer JA, Holzer CE, Soukup VM. Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol. 2006; 1: 410-20.PMID: 18040813
60. Di Chiara G, Bassareo V, Fenu S, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004; 47 Suppl 1: 227-41.PMID: 15464140
61. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162: 1403-13. Review. PMID: 16055761
62. [62] Paris JJ, Carey AN, Shay CF, Gomes SM, He JJ, McLaughlin JP. Effects of conditional central expression of HIV-1 tat protein to potentiate cocaine-mediated psychostimulation and reward among male mice. Neuropsychopharmacology 2014; 39: 380-8.PMID: 23945478
63. [63] Ferris MJ, Frederick-Duus D, Fadel J, Mactutus CF, Booze RM. The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study. Neuroscience 2009; 159: 1292-9.PMID: 19344635
64. [64] Napier TC, Chen L, Kashanchi F, Hu XT. Repeated cocaine treatment enhances HIV-1 Tat-induced cortical excitability via over-activation of L-type calcium channels. J Neuroimmune Pharmacol 2014; 9: 354-368.PMID: 24567038
65. [65] Critchley HD, Rotshtein P, Nagai Y, O'Doherty J, Mathias CJ, Dolan RJ. Activity in the human brain predicting differential heart rate responses to emotional facial expressions. Neuroimage 2005; 24: 751-62.PMID: 15652310
66. [66] Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry 2006; 60: 383-7.PMID: 16780813
67. [67] Naqvi NH, Rudrauf D, Damasio H, Bechara A. Damage to the insula disrupts addiction to cigarette smoking. Science 2007; 315: 531-4.PMID: 17255515
68. [68] Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010; 35: 169-91.PMID: 19625997
69. [69] Kowiański P, Moryś JM, Wojcik S, Dziewiatkowski J, Luczyńska A, Spodnik E, Timmermans JP, Moryś J. Neuropeptide-containing neurons in the endopiriform region of the rat: morphology and colocalization with calcium-binding proteins and nitric oxide synthase. Brain Res. 2004; 996: 97-110.PMID: 14670636
70. [70] Vertes RP. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 2004; 51: 32-58.PMID: 14579424
71. [71] Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, Munsch T. Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS One 2008; 3(7): e2695.PMID: 18628994
72. [72] Bravo-Rivera C, Roman-Ortiz C, Brignoni-Perez E, Sotres-Bayon F, Quirk GJ. Neural structures mediating expression and extinction of platform-mediated avoidance. J Neurosci. 2014; 34: 9736-42.PMID: 25031411
73. [73] Starkstein SE, Robinson RG. Mechanism of disinhibition after brain lesions. J Nerv Ment Dis. 1997; 185: 108-14.PMID: 9048703
74. Herzog D, Killianova T, Pauwels S, Germeys F, Gidron Y. Hemispheric Lateralization Moderates the Life Events-Distress Relationship. Stress Health In press.PMID: 24719310
75. [75] Guilfoyle DN, Helpern JA, Lim KO. Diffusion tensor imaging in fixed brain tissue at 7.0 T. NMR Biomed. 2003; 16: 77-81.PMID: 12730948
76. Nath A. Eradication of human immunodeficiency virus from brain reservoirs. J Neurovirol. in press.PMID: 25366659